Global pandemic preparedness refers to the strategic planning, infrastructure development, and coordinated response mechanisms designed to prevent, detect, and control outbreaks of infectious diseases before they escalate into global crises. It involves strengthening public health systems, investing in rapid diagnostics, vaccine research, medical supply chains, and international collaboration. The COVID-19 experience highlighted the urgent need for resilient healthcare systems, robust surveillance, and cross-border cooperation to manage emerging threats effectively. Preparedness not only saves lives but also mitigates social and economic disruptions worldwide.
Market Analysis: In 2025, the global pandemic preparedness market is valued at approximately USD 78.6 billion, driven by investments in vaccines, diagnostics, AI-based surveillance, and stockpiling of critical medical supplies. With governments, NGOs, and private players expanding funding, the market is projected to reach around USD 128.4 billion by 2030, growing at a CAGR of 10.3%. Rising antimicrobial resistance, frequent zoonotic outbreaks, and demand for digital health solutions are fueling growth. Asia-Pacific and North America are leading the market due to high government spending, while Africa and Latin America are emerging as key regions for future preparedness investments.
